Hence, inhibition of AChE and BChE activities and stimulation of Na+/K+-ATPase activity by tested extracts can provide an avenue for the development of effective drugs of plant origin for the management of cognitive disorders. The gene discussed is ACHE; the disease is cognitive disorder.